Details for New Drug Application (NDA): 017087
✉ Email this page to a colleague
The generic ingredient in ETHRANE is enflurane. There are three drug master file entries for this compound. Additional details are available on the enflurane profile page.
Summary for 017087
Tradename: | ETHRANE |
Applicant: | Baxter Hlthcare |
Ingredient: | enflurane |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017087
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LIQUID;INHALATION | Strength | 99.9% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017087
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | ETHRANE | enflurane | LIQUID;INHALATION | 017087-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | ETHRANE | enflurane | LIQUID;INHALATION | 017087-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription